Core Viewpoint - Gestala Technology, the first domestic company focused on ultrasound brain-machine interfaces, has completed a 150 million yuan angel round financing, setting a record for the highest angel round financing in China's brain-machine interface sector [4][5]. Financing Details - The financing round was led by Guosheng Capital and Daotong Investment, with participation from several well-known investment institutions and companies, including Qingsong Capital and Gobi Partners [4]. - The funds raised will primarily be invested in product development and early clinical trials, focusing on core technology, clinical registration, AI integration, and advanced technology layout [6][7]. Industry Context - The global brain-machine interface industry is experiencing an investment boom, particularly in the "ultrasound track," with notable companies like Merge Labs and Nudge also securing significant funding [5]. - The advantages of ultrasound pathways over traditional invasive electrical methods include non-invasiveness, full-brain "reading and writing," and multi-target neural circuit regulation, addressing a wide range of clinical needs [5][6]. Product Development and Clinical Trials - Gestala Technology plans to establish its headquarters and first production line in Chengdu by the second quarter of this year, with the first product focusing on chronic pain management [6]. - Clinical trials have shown that a single stimulation can reduce pain scale scores by 50%, with effects lasting 1-2 weeks [6]. Strategic Vision - The company aims to create a brain-machine interface platform based on ultrasound with full-brain reading and writing capabilities, providing innovative treatment methods for various neurological diseases and exploring the integration of brain science and artificial intelligence [6][7].

Core Insights - The article discusses the establishment of Gestalt (Chengdu) Technology Co., Ltd., a brain-computer interface (BCI) company focused on ultrasound technology, marking a new direction in China's BCI field [1][3] Company Overview - Gestalt is the first domestic company specializing in ultrasound brain-computer interface technology, aiming to explore next-generation full-brain signal reading, writing, and analysis [1][3] - The company was co-founded by Peng Lei, former co-founder and CEO of Brain Tiger Technology, and Chen Tianqiao, founder of Tianqiao Brain Science Research Institute [1][3] Technology and Innovation - The core philosophy of Gestalt is based on the German concept of "Gestalt," emphasizing that the whole is greater than the sum of its parts [1][3] - Ultrasound BCI technology is seen as the most promising direction for achieving full-brain reading and writing capabilities, allowing for non-invasive precision modulation of specific brain areas [3] - The technology aims to provide innovative treatment for various neurological disorders by enabling multi-target modulation of brain circuits [3] Clinical Applications - Clinical interventions using ultrasound BCI have shown effectiveness in managing chronic pain, stroke-related functional impairments, and depression [3] - Research indicates that modulation of the anterior cingulate cortex (ACC) through ultrasound significantly reduces pain intensity, with effects lasting approximately one week [3] Product Development - Gestalt plans to develop its products in multiple generations, starting with a bench-top device followed by a wearable device, focusing on medical applications [4] - The first product, a magnetic resonance-guided bench-top device, will target chronic pain management, with registration processes expected to begin this year [4]